Harvoni
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AX - Other Antivirals -> J05AX65 - Harvoni
Administration category:
Free
Medicine group:
antiviral
File parts:
ledipasvir
sofosbuvir
Brand name:
Harvoni
Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 90/400mg 1 dd |
||
|
Comments:
= 1 tablet per dag |
||||
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: <30 |
Dosage: veiligheid en effectiviteit niet bewezen |
|||
Renal elimination:
ledipasvir: 1% sofosbuvir: 80%
Dosage:
dependent on kidney function
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-343591.1
Updated: 06/16/2019 - 20:05
Status: Published